We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Hancock Whitney
HWC
$6.24B
| $293K | ﹤0.01% |
6,682
-101,638
| -94% | -$4.12M |
|
|
ACOR
1577
DELISTED
Acorda Therapeutics
ACOR
| $293K | ﹤0.01% |
+1,198
| New | +$302K |
|
1578
Toll Brothers
TOL
$14.5B
| $292K | ﹤0.01% |
+7,400
| New | +$296K |
|
|
TAST
1579
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $287K | ﹤0.01% |
40,717
-77,629
| -66% | -$567K |
|
1580
J.M. Smucker
SJM
$12.8B
| $281K | ﹤0.01% |
+2,700
| New | +$286K |
|
1581
Omeros
OMER
$959M
| $278K | ﹤0.01% |
+19,700
| New | +$288K |
|
1582
AstroNova
ALOT
$227M
| $277K | ﹤0.01% |
+20,200
| New | +$308K |
|
1583
Kamada
KMDA
$419M
| $274K | ﹤0.01% |
+39,935
| New | +$243K |
|
1584
Cadiz
CDZI
$291M
| $271K | ﹤0.01% |
+24,616
| New | +$284K |
|
1585
CTS Corp
CTS
$1.89B
| $268K | ﹤0.01% |
8,941
-32,221
| -78% | -$933K |
|
1586
NN Inc
NNBR
$311M
| $265K | ﹤0.01% |
+28,666
| New | +$230K |
|
|
NVMI
1587
Nova
NVMI
$12.5B
| $265K | ﹤0.01% |
+6,969
| New | +$244K |
|
1588
Jefferies Financial Group
JEF
$13.1B
| $261K | ﹤0.01% |
12,761
-540,573
| -98% | -$10.2M |
|
|
WLL
1589
DELISTED
Whiting Petroleum Corporation
WLL
| $258K | ﹤0.01% |
+469
| New | +$227K |
|
1590
Hecla Mining
HL
$11.3B
| $254K | ﹤0.01% |
+75,000
| New | +$184K |
|
1591
TriMas Corp
TRS
$1.44B
| $254K | ﹤0.01% |
8,075
-32,500
| -80% | -$1M |
|
1592
Southern First Bancshares
SFST
$600M
| $251K | ﹤0.01% |
+5,900
| New | +$246K |
|
|
GBL
1593
DELISTED
GAMCO Investors, Inc.
GBL
| $249K | ﹤0.01% |
+12,757
| New | +$225K |
|
|
OSB
1594
DELISTED
Norbord Inc.
OSB
| $249K | ﹤0.01% |
9,329
-21,071
| -69% | -$562K |
|
|
TRTX
1595
TPG RE Finance Trust
TRTX
$618M
| $247K | ﹤0.01% |
+12,200
| New | +$245K |
|
1596
Metropolitan Bank Holding Corp
MCB
$1.15B
| $246K | ﹤0.01% |
+5,100
| New | +$225K |
|
|
BMTX
1597
DELISTED
BM Technologies, Inc.
BMTX
| $244K | ﹤0.01% |
23,824
-5,966
| -20% | -$60.9K |
|
|
PR
1598
Permian Resources
PR
$16.9B
| $243K | ﹤0.01% |
52,500
-555,154
| -91% | -$2.03M |
|
1599
Graham Corp
GHM
$1.31B
| $241K | ﹤0.01% |
+11,000
| New | +$238K |
|
|
TGH
1600
DELISTED
Textainer Group Holdings limited
TGH
| $240K | ﹤0.01% |
+22,400
| New | +$218K |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.